124 related articles for article (PubMed ID: 2317492)
1. Liposomes with entrapped doxorubicin exhibit extended blood residence times.
Bally MB; Nayar R; Masin D; Hope MJ; Cullis PR; Mayer LD
Biochim Biophys Acta; 1990 Mar; 1023(1):133-9. PubMed ID: 2317492
[TBL] [Abstract][Full Text] [Related]
2. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice.
Mayer LD; Tai LC; Ko DS; Masin D; Ginsberg RS; Cullis PR; Bally MB
Cancer Res; 1989 Nov; 49(21):5922-30. PubMed ID: 2790807
[TBL] [Abstract][Full Text] [Related]
3. Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing mice.
Bally MB; Masin D; Nayar R; Cullis PR; Mayer LD
Cancer Chemother Pharmacol; 1994; 34(2):137-46. PubMed ID: 8194164
[TBL] [Abstract][Full Text] [Related]
4. Studies on the myelosuppressive activity of doxorubicin entrapped in liposomes.
Bally MB; Nayar R; Masin D; Cullis PR; Mayer LD
Cancer Chemother Pharmacol; 1990; 27(1):13-9. PubMed ID: 2245488
[TBL] [Abstract][Full Text] [Related]
5. Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes.
Harasym TO; Cullis PR; Bally MB
Cancer Chemother Pharmacol; 1997; 40(4):309-17. PubMed ID: 9225948
[TBL] [Abstract][Full Text] [Related]
6. Intravenous pretreatment with empty pH gradient liposomes alters the pharmacokinetics and toxicity of doxorubicin through in vivo active drug encapsulation.
Mayer LD; Reamer J; Bally MB
J Pharm Sci; 1999 Jan; 88(1):96-102. PubMed ID: 9874708
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol).
Parr MJ; Masin D; Cullis PR; Bally MB
J Pharmacol Exp Ther; 1997 Mar; 280(3):1319-27. PubMed ID: 9067319
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times.
Gabizon A; Shiota R; Papahadjopoulos D
J Natl Cancer Inst; 1989 Oct; 81(19):1484-8. PubMed ID: 2778836
[TBL] [Abstract][Full Text] [Related]
9. A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: From liposomal preparation to therapy.
Farzaneh H; Ebrahimi Nik M; Mashreghi M; Saberi Z; Jaafari MR; Teymouri M
Int J Pharm; 2018 Nov; 551(1-2):300-308. PubMed ID: 30243944
[TBL] [Abstract][Full Text] [Related]
10. Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia.
Mayer LD; Nayar R; Thies RL; Boman NL; Cullis PR; Bally MB
Cancer Chemother Pharmacol; 1993; 33(1):17-24. PubMed ID: 8269584
[TBL] [Abstract][Full Text] [Related]
11. An improved method of encapsulation of doxorubicin in liposomes: pharmacological, toxicological and therapeutic evaluation.
Gokhale PC; Radhakrishnan B; Husain SR; Abernethy DR; Sacher R; Dritschilo A; Rahman A
Br J Cancer; 1996 Jul; 74(1):43-8. PubMed ID: 8679456
[TBL] [Abstract][Full Text] [Related]
12. Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients.
Mayer LD; Tai LC; Bally MB; Mitilenes GN; Ginsberg RS; Cullis PR
Biochim Biophys Acta; 1990 Jun; 1025(2):143-51. PubMed ID: 2364073
[TBL] [Abstract][Full Text] [Related]
13. Enhanced tumor targeting of doxorubicin by ganglioside GM1-bearing long-circulating liposomes.
Unezaki S; Maruyama K; Ishida O; Takahashi N; Iwatsuru M
J Drug Target; 1993; 1(4):287-92. PubMed ID: 8069570
[TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.
Rahman A; Carmichael D; Harris M; Roh JK
Cancer Res; 1986 May; 46(5):2295-9. PubMed ID: 3697976
[TBL] [Abstract][Full Text] [Related]
15. Liposomal doxorubicin circumvents PSC 833-free drug interactions, resulting in effective therapy of multidrug-resistant solid tumors.
Krishna R; Mayer LD
Cancer Res; 1997 Dec; 57(23):5246-53. PubMed ID: 9393743
[TBL] [Abstract][Full Text] [Related]
16. The role of tumor-associated macrophages in the delivery of liposomal doxorubicin to solid murine fibrosarcoma tumors.
Mayer LD; Dougherty G; Harasym TO; Bally MB
J Pharmacol Exp Ther; 1997 Mar; 280(3):1406-14. PubMed ID: 9067330
[TBL] [Abstract][Full Text] [Related]
17. Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model.
Storm G; Roerdink FH; Steerenberg PA; de Jong WH; Crommelin DJ
Cancer Res; 1987 Jul; 47(13):3366-72. PubMed ID: 3581073
[TBL] [Abstract][Full Text] [Related]
18. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol).
Maruyama K; Yuda T; Okamoto A; Kojima S; Suginaka A; Iwatsuru M
Biochim Biophys Acta; 1992 Sep; 1128(1):44-9. PubMed ID: 1390877
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of stealth versus conventional liposomes: effect of dose.
Allen TM; Hansen C
Biochim Biophys Acta; 1991 Sep; 1068(2):133-41. PubMed ID: 1911826
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological, toxicological, and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes.
Rahman A; White G; More N; Schein PS
Cancer Res; 1985 Feb; 45(2):796-803. PubMed ID: 3967247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
